Latest News

Latest News

COVID-19 Vaccines Deemed Safe for Patients With Solid Tumors

By

Leah Lawrence

Publish Date March 23, 2023

Patients with solid tumors do not appear to have an increased risk of side effects from COVID-19 vaccination, according to a systematic review.

Adding Ipilimumab to Standard Care Improves Responses in Operable NSCLC

By

Leah Lawrence

Publish Date March 23, 2023

Adding ipilimumab to nivolumab and chemotherapy improves responses in patients with operable non-small cell lung cancer, a phase 2 trial suggests.

Pentagon Study Finds Higher Cancer Rates Among Pilots, Ground Crews

Publish Date March 23, 2023

Military pilots and the ground crews who fuel and maintain their aircraft have higher rates of certain cancers, a new study shows.

Trial Investigating Pembrolizumab for Hormone-Sensitive Prostate Cancer Discontinued

By

Diana Ernst, RPh

Publish Date March 23, 2023

Merck has decided to end the phase 3 KEYNOTE-991 trial due to futility.

Ulenistamab Fast Tracked for Advanced/Metastatic Pancreatic Cancer

By

Diana Ernst, RPh

Publish Date March 23, 2023

Ulenistamab targets PAUF, a tumor-specific protein that is overexpressed in pancreatic cancer cells.

Adverse Birth Outcomes More Common Among AYAs With Cancer During Pregnancy

By

Andrea S. Blevins Primeau, PhD, MBA

Publish Date March 22, 2023

Adolescent and young adult patients diagnosed with cancer during pregnancy have a higher risk of adverse birth outcomes, a study suggests.

Comparable Outcomes With and Without Neoadjuvant Therapy in High-Risk Melanoma

By

Leah Lawrence

Publish Date March 22, 2023

Patients with high-risk, stage III melanoma have similar outcomes whether they undergo surgery upfront or receive immunotherapy prior to surgery, a study suggests.

Surgical Resection Improves Long-Term Outcomes in T1 Colorectal Cancer

By

Andrea S. Blevins Primeau, PhD, MBA

Publish Date March 22, 2023

Surgical resection generally improves long-term outcomes over local resection in high-risk, T1 colorectal cancer, a study suggests.

Hormone Therapy Linked to Lower Risk of Lung Cancer in Postmenopausal Women

Publish Date March 22, 2023

Patients receiving higher doses of hormone therapy and those receiving hormone therapy for at least 5 years may have a lower risk of lung cancer.

Discrimination Tied to Frailty in African-American Cancer Survivors

Publish Date March 22, 2023

Among African-American cancer survivors, experiencing discrimination is associated with frailty, a study suggests.